Profile
IMRN NVO VRTX REGN SGEN ALNY
Company Name Immuron Limited Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $12.72M $530.78B $125.13B $109.96B $43.15B $36.37B
Employees 0.01K 69.26K 5.40K 13.93K 3.26K 2.10K
CEO Dr. Jerry Kanellos Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
IMRN NVO VRTX REGN SGEN ALNY
Quant Rating Score 1 3 2 4 3 2
Quant Rating Strong Sell Neutral Sell Buy Neutral Sell
Trading
IMRN NVO VRTX REGN SGEN ALNY
Last Close $2.2199 $119.78 $484.82 $1014.25 $228.74 $283.32
High 52 $3.83 $146.91 $505.78 $1201.76 $228.9 $287.01
Low 52 $1.48 $93.5 $343 $775.18 $211.85 $143.31
Price vs. 52 Week High -42.04 % -18.47 % -4.14 % -15.6 % -0.07 % -1.29 %
Price vs. 52 Week Low 49.99 % 28.11 % 41.35 % 30.84 % 7.97 % 97.7 %
Total Return
IMRN NVO VRTX REGN SGEN ALNY
1 Month Return -17.48 % -12.57 % -0.11 % -12.06 % 0 % 6.8 %
3 Month Return -8.46 % -15.28 % -1.23 % -6.27 % 0 % 10.59 %
6 Month Return -14.29 % -3.33 % 22.01 % 12.88 % 0 % 91.82 %
9 Month Return 13.26 % 11.78 % 11.86 % 8.69 % 0 % 46.5 %
YTD Return 18.39 % 15.79 % 19.15 % 15.48 % 0 % 48.02 %
1 Year Return 18.08 % 17.27 % 30.68 % 20.8 % 6.87 % 68.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
IMRN NVO VRTX REGN SGEN ALNY
Dividend Yield Percentage (TTM) - 1.2 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -8368.56 % 1.26 % -1.96 % 4.72 % -3.35 % 6.97 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.71 % - - - -
Growth
IMRN NVO VRTX REGN SGEN ALNY
Asset Growth -29.28 % 30.35 % 25.23 % 13.23 % -1.21 % 7.99 %
Gross Profit Growth 154.88 % 32.32 % 9.25 % 6.49 % 22.93 % 74.75 %
Revenue Growth 171.67 % 31.26 % 10.17 % 7.76 % 24.65 % 76.23 %
Revenue 3 Year 3158.24 % 90.51 % 59.87 % 55.67 % 91.84 % 241.5 %
Revenue 5 Year 30.26 % 124.2 % 218.58 % 110.3 % 215.48 % 1865.57 %
Revenue 10 Year -97.83 % 66.11 % 608.27 % 549.62 % 494.04 % 1810.11 %
EBIT Growth -141.65 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Net Income Growth -83.2 % 50.71 % 8.96 % -8.87 % 9.51 % 61.08 %
Net Income 3 Yeari Growth Per Share 19.98 % 106.79 % 34.59 % 13.48 % -764.83 % 52.78 %
Net Income 5 Yeari Growth Per Share 5.27 % 133.86 % 70.33 % 74.02 % -276.93 % 53.44 %
Net Income 10 Yeari Growth Per Share 98.74 % 98.61 % 809.6 % 871.12 % -624.16 % -143.14 %
Operating Income Growth -141.65 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Operating Cash Flow Growth (CFG) -114.24 % 38.06 % -14.35 % -8.39 % 9.07 % 119.24 %
Operating 3 Year CFG -32.06 % 118.29 % 9.63 % 76.95 % -148.34 % 115.59 %
Operating 5 Year CFG -96.08 % 163.51 % 174.78 % 125.17 % -195.86 % 114.91 %
Operating 10 Year CFG 99.03 % 150.92 % 6084.35 % 713.56 % -2622.09 % 174.76 %
EPS Growth -83.13 % 52.28 % 8.33 % -8.54 % 10.81 % 62.15 %
EPS Diluted Growth -83.13 % 52.37 % 8.35 % -9.03 % 10.81 % 62.15 %
Book Value Per Share -35.32 % 29 % 25.58 % 15.03 % -9.83 % -35.86 %
Share Holder 3 Year Equity Growth Per Share -52.45 % 75.22 % 104.06 % 137.56 % 33.92 % -119.99 %
Share Holder 5 Year Equity Growth Per Share 9.66 % 121.9 % 291.14 % 219.1 % 220.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share -99.13 % 49.62 % 1030.79 % 1286.9 % 691.19 % -140.22 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -100 % 4.74 % 44.1 % 0.06 % -23.28 % 103.19 %
Free Cash Flow Growth -113.61 % 9.17 % -16.47 % -17.11 % 3.67 % 106.84 %
Updated On 30 Jun 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
IMRN NVO VRTX REGN SGEN ALNY
Gross Profit Margin TTM 68.59 % 84.53 % 86.43 % 86.08 % 75.4 % 87 %
Return on Assets TTM -62.9 % 24.34 % -2.43 % 11.98 % -20.64 % -1.82 %
Return on Equity TTM -58.07 % 87.5 % -2.91 % 16.3 % -28.06 % 47.92 %
Return on Capital Employed TTM -94.45 % 61.51 % -2.36 % 12.08 % -29.5 % 3.47 %
Net Income Per EBT TTM 107.23 % 79.6 % -228.18 % 94.21 % 101.53 % 118.22 %
EBT Per Ebit TTM 75.15 % 101.17 % -54.74 % 116.55 % 93.47 % -60.11 %
EBIT Per Revenue TTM -166.23 % 43.26 % -3.8 % 29.18 % -34.37 % 4.38 %
Cash Flow To Debt Ratio TTM -4181.94 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Receivables Turnover TTM 5.26 3.88 6.23 2.36 3.64 7.58
Payables Turnover TTM 3.53 1.34 4.27 3.34 2.52 4.12
Inventory Turnover TTM 1.45 1.1 1.53 0.65 1.07 3.63
Fixed Asset Turnover TTM 4730.71 % 234.59 % 583 % 313.27 % 471.71 % 327.68 %
Asset Turnover TTM 46.96 % 69.85 % 51.28 % 37.38 % 63.3 % 58.47 %
Operating Cash Flow Per Share TTM -0.03 25.87 -3.66 37.65 -2.87 2.94
Free Cash Flow Per Share TTM -0.03 14.81 -5.52 29.68 -3.73 2.52
Cash Per Share TTM 5.11 % 1405.52 % 2245.45 % 9080.94 % 657.5 % 2071.01 %
Operating Cash Flow Sales Ratio TTM -99.37 % 44.7 % -9.14 % 30.18 % -23.48 % 15.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.01 % 57.25 % 151.04 % 78.82 % 129.82 % 85.66 %
Cash Flow Coverage Ratios TTM -4181.94 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Price To Free Cash Flows Ratio TTM -2.61 54.96 -87.76 34.27 -61.54 114.07
Price To Operating Cash Flows Ratio TTM -104.07 31.65 -132.56 26.94 -79.67 96.45
Price Cash Flow Ratio TTM -104.07 31.65 -132.56 26.94 -79.67 96.45
Income Statement (TTM)
IMRN NVO VRTX REGN SGEN ALNY
Revenue $0B $232.26B $9.84B $13.12B $1.96B $1.83B
Gross Profit $0B $196.5B $8.58B $11.3B $1.55B $1.52B
Gross Profit Ratio 68.06% 84.6% 87.17% 86.16% 79.1% 83.02%
EBITDA $-0.01B $112.94B $3.93B $5.13B $-0.62B $-0.23B
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.44B
EPS Diluted -0.03 18.62 13.89 34.77 -3.3 -3.52
Balance Sheet (MRQ)
IMRN NVO VRTX REGN SGEN ALNY
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $2.34B
Total Liabilities $0B $207.93B $5.15B $7.11B $0.87B $4.05B
Total Equity $0.01B $106.56B $17.58B $25.97B $2.8B $-0.22B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.68B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $2.68B
Total Assets $0.02B $314.49B $22.73B $33.08B $3.67B $3.83B
Cash Flow Statement (TTM)
IMRN NVO VRTX REGN SGEN ALNY
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.44B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.02B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $0.1B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.13
ABCL AbCellera Biologics Inc. 2.56
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.54
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.33
ABSI Absci Corporation 3.98
ABUS Arbutus Biopharma Corporation 4.11
ABVC ABVC BioPharma, Inc. 0.5871
ABVX Abivax SA American Depositary Shares 9.48
ACAD ACADIA Pharmaceuticals Inc. 14.91
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.4
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.985
ACHV Achieve Life Sciences, Inc. 5.005
ACIU AC Immune SA 3.2
ACLX Arcellx, Inc. 89.91
ACRV Acrivon Therapeutics, Inc. Common Stock 7.6
ACST Acasti Pharma Inc. 3.39
Unlock